INVOKANA® has been proven to:

Invokana logo in the shape of a pair of kidneys

In adults with type 2 diabetes and diabetic kidney disease

Lower the risks of end-stage kidney disease and hospitalization for heart failure

INVOKANA® is the only type 2 diabetes medicine proven to lower the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular death, and hospitalization for heart failure in adults with type 2 diabetes and diabetic kidney disease (nephropathy) with a certain amount of protein in the urine.

Invokana logo in the shape of a heart

In adults with type 2 diabetes and established cardiovascular disease

Lower the risk of major cardiovascular events

INVOKANA® has been proven to lower the risk of heart attack, stroke, and cardiovascular death.

Invokana logo in the shape of a drop of water

In adults with type 2 diabetes

Lower A1C

INVOKANA® along with diet and exercise, has been proven to lower blood sugar (A1C). In most clinical studies, INVOKANA® helped a majority of people reach the ADA-recommended A1C goal of <7%.

Invokana logo in the shape of a siren

Most common side effects

The most common side effects of INVOKANA® include genital yeast infections, urinary tract infections, and changes in urination.

INVOKANA® is now the first drug approved in almost 20 years to lower the risk of end-stage kidney disease in people with diabetic kidney disease and type 2 diabetes.

Your doctor can detect early stages of diabetic kidney disease. If you have type 2 diabetes, talk to your doctor about INVOKANA®.
Make an appointment today.